Krebs cycle enzymes as tumor suppressors

Drug Discovery Today: Disease Mechanisms

Volumn 2, Issue 2, 2005, Pages 247-254

  Baysal, Bora E ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOGLUTARIC ACID; BENZOIC ACID; CALPONIN; CALPONIN H1; FUMARATE HYDRATASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PHENYLACETIC ACID; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN BNIP3; SUCCINATE DEHYDROGENASE; TAMOXIFEN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

AUTOSOMAL DOMINANT DISORDER; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CATALYSIS; CITRIC ACID CYCLE; DRUG TARGETING; FAMILIAL CANCER; GENE INACTIVATION; GENETIC SUSCEPTIBILITY; GERM LINE; HUMAN; KIDNEY CARCINOMA; LEIOMYOMA; LEIOMYOMATOSIS; LEIOMYOSARCOMA; MALIGNANT TRANSFORMATION; MOLECULAR CLONING; MUTATIONAL ANALYSIS; NONHUMAN; PARAGANGLIOMA; REVIEW; TUMOR SUPPRESSOR GENE; UTERUS MYOMA;

EID: 33645062154     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2005.05.012     Document Type: Review

References (42)

1. C.J. Sherr Principles of tumor suppression Cell 116 2004 235-246
2. B.E. Baysal et. al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma Science 287 2000 848-851
3. I.P. Tomlinson et. al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer Nat. Genet. 30 2002 406-410
4. G. Cecchini Function and structure of complex II of the respiratory chain Annu. Rev. Biochem. 72 2003 77-109
5. V. Yankovskaya et. al. Architecture of succinate dehydrogenase and reactive oxygen species generation Science 299 2003 700-704
6. T. Suzuki et. al. Rat liver mitochondrial and cytosolic fumarases with identical amino acid sequences are encoded from a single gene J. Biol. Chem. 264 1989 2581-2586
7. S.A. Woods et. al. Two biochemically distinct classes of fumarase in Escherichia coli Biochim. Biophys. Acta 954 1988 14-26
8. T. Bourgeron et. al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency Nat. Genet. 11 1995 144-149
9. T. Bourgeron et. al. Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency J. Clin. Invest. 93 1994 2514-2518
10. C. Eng et. al. A role for mitochondrial enzymes in inherited neoplasia and beyond Nat. Rev. Cancer 3 2003 193-202
11. P.J. Pollard et. al. The TCA cycle and tumorigenesis: The examples of fumarate hydratase and succinate dehydrogenase Ann. Med. 35 2003 632-639
12. C.P. Pavlovich et. al. Searching for the hereditary causes of renal-cell carcinoma Nat. Rev. Cancer 4 2004 381-393
13. P.H. Maxwell et. al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature 399 1999 271-275
14. J.R. Toro et. al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America Am. J. Hum. Genet. 73 2003 95-106
15. H.P. Neumann et. al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations JAMA 292 2004 943-951
16. P. Pollard et. al. Evidence of increased microvessel density and activation of the hypoxia pathway in tumours from the hereditary leiomyomatosis and renal cell cancer syndrome J. Pathol. 205 2005 41-49
17. B.E. Baysal Genomic imprinting and environment in hereditary paraganglioma Am. J. Med. Genet. C Semin. Med. Genet. 129 2004 85-90
18. G.P. Flake et. al. Etiology and pathogenesis of uterine leiomyomas: A review Environ. Health Perspect. 111 2003 1037-1054
19. B.E. Baysal Hereditary paraganglioma targets diverse paraganglia J. Med. Genet. 39 2002 617-622
20. D. Astuti et. al. Gene mutations in the succinate dehydrogenase subunit sdhb cause susceptibility to familial pheochromocytoma and to familial paraganglioma Am. J. Hum. Genet. 69 2001 49-54
21. S. Niemann U. Muller Mutations in SDHC cause autosomal dominant paraganglioma, type 3 Nat. Genet. 26 2000 268-270
22. B.E. Baysal et. al. An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma J. Med. Genet. 41 2004 703-709
23. A.G. van der Mey et. al. Genomic imprinting in hereditary glomus tumours: Evidence for new genetic theory Lancet 2 1989 1291-1294
24. B.E. Baysal et. al. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas J. Med. Genet. 39 2002 178-183
25. H.P. Neumann et. al. Germ-line mutations in nonsyndromic pheochromocytoma N. Engl. J. Med. 346 2002 1459-1466
26. A.L. Young et. al. Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene J. Clin. Endocrinol. Metab. 87 2002 4101-4105
27. A.P. Gimenez-Roqueplo et. al. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas Cancer Res. 63 2003 5615-5621
28. A.P. Gimenez-Roqueplo et. al. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway Am. J. Hum. Genet. 69 2001 1186-1197
29. K. Astrom et. al. Altitude is a phenotypic modifier in hereditary paraganglioma type 1: Evidence for an oxygen-sensing defect Hum. Genet. 113 2003 228-237
30. J.I. Piruat et. al. The mitochondrial SDHD gene is required for early embryogenesis, and its partial deficiency results in persistent carotid body glomus cell activation with full responsiveness to hypoxia Mol. Cell Biol. 24 2004 10933-10940
31. N. Ishii et. al. A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes Nature 394 1998 694-697
32. T. Ishii et. al. A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis Cancer Res. 65 2005 203-209
33. M.A. Selak et. al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase Cancer Cell 7 2005 77-85
34. C.W. Pugh P.J. Ratcliffe The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis Semin. Cancer Biol. 13 2003 83-89
35. M. Safran W.G. Kaelin Jr. HIF hydroxylation and the mammalian oxygen-sensing pathway J. Clin. Invest. 111 2003 779-783
36. R. Paddenberg et. al. Essential role of complex II of the respiratory chain in hypoxia-induced ROS generation in the pulmonary vasculature Am. J. Physiol. Lung Cell Mol. Physiol. 284 2003 L710-L719
37. G. Cecchini et. al. Variation in proton donor/acceptor pathways in succinate:qUinone oxidoreductases FEBS Lett. 545 2003 31-38
38. M. Kiuru et. al. Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families Cancer Res. 62 2002 4554-4557
39. K.L. Gross et. al. Involvement of fumarate hydratase in nonsyndromic uterine leiomyomas: Genetic linkage analysis and FISH studies Genes Chromosomes Cancer 41 2004 183-190
40. N.A. Alam et. al. Clinical features of multiple cutaneous and uterine leiomyomatosis: An underdiagnosed tumor syndrome Arch. Dermatol. 141 2005 199-206
41. A. Horiuchi et. al. Possible role of calponin h1 as a tumor suppressor in human uterine leiomyosarcoma J. Natl. Cancer Inst. 91 1999 790-796
42. Brusilow S.W. Horwich A.L. 2001 Urea Cycle Enzymes (8th edn) 1948-1949 McGraw-Hill